Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: They Have Money

Well

 

they are giving / paying with STOCK

 

Pursuant to the term-sheet, Mosaic will issue Oncotelic shares of its common stock valued at
$15.0 million upon execution of the definitive agreement, or a combination common stock and
preferred stock to be determined by the parties, along with additional milestones allowing
Oncotelic to earn up to an additional $15.0 million in shares of common stock valued at the time
of issuance, if earned.

 

So where are the 15 $ Million in stock coming from

 

$15M @ .50 cents per share - thats 30 Million shares

 

If they give them 30 Million shares - Oncotelic is going to WANT those Shares to GO UP IN PRICE

 

I SAY:

STRONG BUY RIGHT NOW !

Share
New Message
Please login to post a reply